Managing acid reflux involves lifestyle adjustments to reduce symptoms and prevent discomfort. Strengthening the lower esophageal sphincter can help prevent acid from rising into the esophagus. Avoiding smoking,…
Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum, causing symptoms like abdominal pain, bloody diarrhea, rectal urgency, and fatigue. Sanjay Murthy, MD,…
Joseph Romagnuolo, MD, MSc, FRCPC with the Medical University of South Carolina talks about the latest research in endoscopic surgery and ultrasound. References and Resources Dietric, C., et…
Dr. Christine Lau at the University of Virginia Health System goes over treatment options for early and late stage esophageal cancer. References and Resources Daly, J., et al.…
Thomas Byrne, MD, Director, MUSC Bariatric Surgery Program, Charleston, South Carolina, argues the case for insurance coverage of bariatric surgeries. References and Resources American Society for Metabolic &…
Christine L. Lau, MD, Assistant Professor of Surgery, University of Virginia Health System, Charlottesville, VA, goes over the procedure for diagnosing and treating esophageal cancer. References and Resources…
Target Audience: This activity has been designed to meet the educational needs of gastroenterologists who provide or manage care for individuals with diseases of the gastrointestinal tract. Learning…
Brenda J. Hoffman, MD, Professor, Division of Gastroenterology, Medical University of South Carolina, Charleston, SC, discusses colon cancer screening in the African-American population. References and Resources Sharma S,…
Partnership to Fight Chronic Disease is a national coalition of patients, providers, community organizations, business and labor groups and health policy experts, committed to raising awareness of policies…
Peter B. Cotton, MD, FRCP, Professor, Gastroenterology and Hepatology, Medical University of South Carolina, discusses the use of capsule endoscopy. References and Resources Sandrasegaran K, Maglinte DD, Jennings…
As presented at ASCO, second-line bevacizumab (Avastin) as monotherapy has been associated with a 28% response rate and an overall survival edge for refractory glioblastoma. Also presented at…
A 50-week, placebo-controlled trial shows that combining infliximab and methotrexate provides no extra benefit in treating Crohn’s disease. References and Resources Feagan B. A randomized trial of methotrexate…